GlaxoSmithKline
First-ever injectable HIV prevention drug to be produced generically
July 28 by Leila HawkinsGeneric versions of new HIV prevention drug to be produced in low and lower-middle income regions
Quarter 2 in Review – The Highlights
July 01 by Chanice HenryThe second quarter of 2015 hosted a raft of activity from the pharma and cold chain industries. This was seen in the form of mergers, landmark agreements, product launches as well as a nationwid...
World’s Largest Collection of Deprioritised Pharma Compounds Opens to Researchers
December 08 by Pharma IQ NewsA collection of 68 deprioritised pharmaceutical compounds1 is being made available to academic researchers through a partnership between the Medical Research Council (MRC) and seven global drug comp...
Flurry of Big Pharma Deals ‘Makes Sense’
April 22 by Pharma IQ NewsNovartis and GlaxoSmithKline have agreed to exchange assets and combine their consumer healthcare units. Novartis has also agreed to sell its animal health division to Lilly for nearly $5.4bn. Ali...
Pharma Industry Report: A Global Guide to Clinically Relevant Drug Transporters
May 24 by Pharmaceuticals & Biotechnology EditorIn this 10 page pharma industry report we look at drug transporter outsourcing, intelligent drug development applied to clinically relevant drug transporters and drug transporters in ADME....
Is it Time for Process Excellence in Pharma R&D?
December 19 by Diana DavisFor years pharmaceutical companies could rake in high margins on drugs that were protected by patents. But as many patents have expired or are near expiration – so much so that the industry is...
How to Predict the Absorption Rate of New Chemical Entities
February 23 by Pharmaceuticals & Biotechnology EditorCurrent estimates indicate that 40% of drugs on the market place and 90% of APIs in development are poorly soluble. David Elder, Externalisation Director for GlaxoSmithKline and Pharma IQ Advisory B...
GSK's Peter Murray: Top Tips for Effective 3rd Party Management
September 21 by Pharmaceuticals & Biotechnology EditorPeter Murray, Quality Director External Supply Strategy, GlaxoSmithKline, provides an overview of GSK's contract manufacturing strategy. In this interview with Andrea Charles from Pharma IQ, Mur...
Health Technology Assessment Goes Online
June 22 by Pharma IQ NewsPharma IQ is pioneering new HTA discussion platform with launch of the first ever HTA Online event - Global HTA and CER Forum, which will take an innovative form of 12 online session over the course o...
Industry to Meet as MHRA, the Dutch Healthcare Inspectorate and the PDA Join 30 Industry Leaders Sharing their Views on Innovation in Clinical Trial Supply Practice and Regulations
November 03 by Pharma IQ NewsIn the wake of a transformed pharmaceutical market due to mergers and acquisitions, industry leaders are to converge in Rotterdam on 27th-28th January 2011, to discuss the latest push in cost cuttin...
A GSK Case Study: Supporting Both HTS And Multiple Hit Strategies With Flexible Processes
July 02 by Pharmaceuticals & Biotechnology EditorImplementing and Managing a Lean Six Sigma Culture in Biopharmaceuticals
March 16 by Pharma IQLyndi Gillespie and Deepa Kumar, Operational Excellence experts within Global Manufacturing and Supply Biopharmaceuticals for GlaxoSmithKline, speak to Pharma IQ about the Lean Six Sigma culture in...